glp-1 going away New research is taking a closer look at what can happen a year or more after people stop taking medications Are Compounded GLP-1s Going Away?

Even when its wanted

In HepG2 and Huh7 cells expressing GLP-1R, exendin-4 treatment led to the phosphorylation of key mediators of the insulin-signaling pathway

Kumarathurai P, Anholm C, Larsen BS, Olsen RH, Madsbad S, Kristiansen O, et al

65 years), baseline eGFR ( 40%), treatment with 10 mg empagliflozin for a median time of 26.2 months reduced the risk of a composite of CV death or hospitalization for HF by 21%, and effect which was mainly related to a 29% lower risk of hospitalization for HF

FeatureCounts: An efficient general purpose program for assigning sequence reads to genomic features

APTF-2 directly regulates glp-1 expression C